Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples

Journal of Mass Spectrometry

Volumn 46, Issue 2, 2011, Pages 163-171

  Dresen, Sebastian ^a,b   Kneisel, Stefan ^a   Weinmann, Wolfgang ^c   Zimmermann, Ralf ^b,d   Auẅarter, Volker ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

aminoalkylindoles; LC MS MS; methanandamide; Spice; synthetic cannabinoids

Indexed keywords

ACTIVE COMPOUNDS; AMINOALKYLINDOLES; BIOLOGICAL SAMPLES; CANNABINOIDS; CONTROL MEASURES; DRUG-SCREENING; EUROPEAN COUNTRIES; FORENSIC SAMPLES; HERBAL MIXTURES; HUMAN SERUM; LC-MS/MS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID-LIQUID EXTRACTION; METHANANDAMIDE; NEW PRODUCT; SERUM SAMPLES; SYNTHETIC CANNABINOIDS; TOXICOLOGICAL ANALYSIS;

BODY FLUIDS; DETOXIFICATION; DRUG PRODUCTS; HOSPITALS; LAW ENFORCEMENT; LIQUIDS; MASS SPECTROMETRY; MIXTURES; SOLVENT EXTRACTION;

LIQUID CHROMATOGRAPHY;

1 BUTYLY 3 (1(4 METHYL)NAPHTHOYL)INDOLE DERIVATIVE; 2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 (1 NAPHTHOYL) 1 PENTYLINDOLE; AMINOALKYLINDOLE; CANNABINOID DERIVATIVE; INDOLE DERIVATIVE; JWH 081; JWH 200; JWH 250; METHANANDAMIDE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CHEMICAL STRUCTURE; DRUG DETOXIFICATION; EXTRACTION; FORENSIC MEDICINE; HUMAN; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; SYNTHESIS; TANDEM MASS SPECTROMETRY;

ARACHIDONIC ACIDS; CANNABINOIDS; CHROMATOGRAPHY, LIQUID; DRUG STABILITY; FEMALE; FORENSIC SCIENCES; HUMANS; INDOLES; MALE; REPRODUCIBILITY OF RESULTS; STREET DRUGS; TANDEM MASS SPECTROMETRY;

CANNABIS;

EID: 79951683329     PISSN: 10765174     EISSN: 10969888     Source Type: Journal    
DOI: 10.1002/jms.1877     Document Type: Article

References (28)

1. V. Auwärter, S. Dresen, W. Weinmann, M. Müller, M. Pütz, N. Ferreirõs,. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J. Mass Spectrom. 2009, 44, 832.
2. N. Uchiyama, R. Kikura-Hanajiri, N. Kawahara, Y. Haishima, Y. Goda,. Identification of a cannabinoid analog as a new type of designer drug in a herbal product. Chem. Pharm. Bull. (Tokyo) 2009, 57, 439.
3. News Item DPA, THC Pharm Frankfurt, Germany (15.12.2008).
4. R. Lindigkeit, A. Boehme, I. Eiserloh, M. Luebbecke, M. Wiggermann, L. Ernst, T. Beuerle,. Spice: a never ending story? Forensic Sci. Int. 2009, 191, 58.
5. V. Auwärter, N. Ferreirõs, S. Dresen, M. Müller, W. Weinmann, M. Pütz,. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? XVI GTFCh-Symposium, Mosbach, Germany, 2009.
6. F. Westphal, T. Junge, F. Sönnichsen, P. Rösner, J. Schäper,. Ein neuer Wirkstoff in SPICE-artigen Kräutermischungen: Charakterisierung von JWH-250, seinen Methyl-und Trimethylsilylderivaten (A new compound in herbal mixtures: characterisation of JWH-250, its methyl- and trimethylsilyl-derivatives). Toxichem. Krimtech. 2010, 77 (1), 8.
7. S. Hudson, J. Ramsey, L. King, S. Timbers, S. Maynard, P. I. Dargan, D. M. Wood,. Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in 'herbal high' products. J. Anal. Toxicol. 2010, 34, 252.
8. S. Dresen, N. Ferreirõs, M. Pütz, F. Westphal, R. Zimmermann, V. Auwärter,. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. J. Mass Spectrom. 2010, 45, 1186.
9. N. Uchiyama, R. Kikura-Hanajiri, J. Ogata, Y. Goda,. Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Sci. Int. 2010, 198, 31.
10. W. A. Devane, F. A. Dysarz III, M. R. Johnson, L. S. Melvin, A. C. Howlett,. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 1988, 34, 605.
11. L. A. Matsuda, S. J. Lolait, M. J. Brownstein, A. C. Young, T. I. Bonner,. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346, 561.
12. S. Munro, K. L. Thomas, M. Abu-Shaar,. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365, 61.
13. T. W. Klein, H. Friedman, S. Specter,. Marijuana, immunity and infection. J. Neuroimmunol. 1998, 83, 102.
14. J. L. Croxford,. Therapeutic potential of cannabinoids in CNS disease. CNS Drugs 2003, 17, 179.
15. W. L. Dewey,. Cannabinoid pharmacology. Pharmacol. Rev. 1986, 38, 151.
16. M. R. Johnson, L. S. Melvin, T. H. Althuis, J. S. Bindra, C. A. Harbert, G. M. Milne, A. Weissman,. Selective and potent analgetics derived from cannabinoids. J. Clin. Pharmacol. 1981, 21, 271S.
17. Advisory Council on the Misuse of Drugs. Consideration of the major cannabinoid agonists, 2009.
18. M. M. Aung, G. Griffin, J. W. Huffman, M. Wu, C. Keel, B. Yang, V. M. Showalter, M. E. Abood, B. R. Martin,. Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding. Drug Alcohol Depend. 2000, 60, 133.
19. J. W. Huffman, G. Zengin, M. J. Wu, J. Lu, G. Hynd, K. Bushell, A. L. Thompson, S. Bushell, C. Tartal, D. P. Hurst, P. H. Reggio, D. E. Selley, M. P. Cassidy, J. L. Wiley, B. R. Martin,. Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists. Bioorg. Med. Chem. 2005, 13, 89.
20. J. W. Huffman, L. W. Padgett,. Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes. Curr. Med. Chem. 2005, 12, 1395.
21. V. M. Showalter, D. R. Compton, B. R. Martin, M. E. Abood,. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther. 1996, 278, 989.
22. G. A. Thakur, S. P. Nikas, A. Makriyannis,. CB1 cannabinoid receptor ligands. Mini Rev. Med. Chem. 2005, 5, 631.
23. S. L. Palmer, A. D. Khanolkar, A. Makriyannis,. Natural and synthetic endocannabinoids and their structure-activity relationships. Curr. Pharm. Des. 2000, 6, 1381.
24. J. Teske, J. P. Weller, A. Fieguth, T. Rothamel, Y. Schulz, H. D. Troger,. Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2010, 878, 2659.
25. S. Dresen, M. Gergov, L. Politi, C. Halter, W. Weinmann,. ESI-MS/MS library of 1,253 compounds for application in forensic and clinical toxicology. Anal. Bioanal. Chem. 2009, 395, 2521.
26. A. S. Christophersen,. Tetrahydrocannabinol stability in whole blood: plastic versus glass containers. J. Anal. Toxicol. 1986, 10, 129.
27. B. K. Matuszewski, M. L. Constanzer, C. M. Chavez-Eng,. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75, 3019.
28. F. T. Peters, M. Hartung, M. Herbold, G. Schmitt, T. Daldrup, F. MuÃhoff,. Anhang B zu den Richtlinien der GTFCh zur Qualitä tssicherung bei forensisch-toxikologischen Untersuchungen; Anforderungen an die Validierung von Analysenmethoden. Toxichem. Krimtech. 2009, 76, 185.